A comparison between 2023 and 2024 demonstrates a clear trend toward increased adoption of biosimilars among naïve patients ( Table 2 ).
← all excerpts
Ensuring Sustainability in Pharmaceutical Care: A Retrospective Analysis of Administrative Databases on the Utilization, Costs, and Switching Patterns of Biological Therapies in the Agency for Health Protection of the Metropolitan Area of Milan.
2
—
—
The sentences
This indicates a strong trend toward the implementation of the biosimilar formulation.